Novabay Pharmaceuticals Inc (AMEX:NBY) price on Thursday, May 09,rose 0.34% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.09.
A look at the stock’s price movement, the close in the last trading session was $0.09. Turning to its 52-week performance, $1.28 and $0.06 were the 52-week high and 52-week low respectively. Overall, NBY moved -2.40% over the past month.
Novabay Pharmaceuticals Inc’s market cap currently stands at around $3.22 million.
Turning to the stock’s technical picture we see that short term indicators suggest on average that NBY is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
NBY’s current price about 6.46% and -19.04% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 46.26, while 7-day volatility ratio is 12.80% and 12.95% in the 30-day chart. Further, Novabay Pharmaceuticals Inc (NBY) has a beta value of 1.87, and an average true range (ATR) of 0.01.
If we refocus on Novabay Pharmaceuticals Inc (AMEX:NBY), historical trading data shows that trading volumes averaged 2.43 million over the past 3 months. The company’s latest data on shares outstanding shows there are 36.06 million shares.
The 0.04% of Novabay Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 3.30% of the company’s shares. Current price change has pushed the stock -56.23% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the NBY stock continues to rise going into the next quarter.